Home » FAQ
Compression Skin Contouring (CoCo) is Osheru’s patented, minimally invasive platform for facial rejuvenation. CoCo uses controlled tissue compression to remove excess skin safely, enabling bloodless, sutureless, and rapid recovery procedures.
Ziplyft applies the CoCo technique through a uniquely designed clamp and precision blade, gently compressing and excising redundant eyelid skin. This creates a smooth contour and enables closure using only adhesive—without stitches, cautery, or significant bruising.
Ziplyft is performed in the office in about 10 minutes, requires only local anesthetic, uses no sutures or cautery, and achieves rapid, natural recovery using adhesive closure. Traditional eyelid lifts are more invasive, take 30–60 minutes, rely on stitches, and require 2–3 weeks of downtime.
Ziplyft is a minimally invasive lid lift (MILL), not classic surgery. It uses the CoCo technique for tissue removal but avoids the cutting, bleeding, and recovery associated with traditional surgical approaches.
The Ziplyft clamp gently compresses the targeted skin, creating a tourniquet effect that seals blood vessels. This allows the blade to remove excess skin without bleeding. The resulting edges are easily and securely sealed with medical adhesive.
Yes. Ziplyft is an FDA Class I, 510(k) exempt medical device—a low-risk category for patient and practitioner safety.
Over 130+ patients have been treated with Ziplyft by 8 surgeons. Results show consistent 10-minute case times, less bruising, rapid return-to-event, and a low complication rate, with peer-reviewed and ongoing multicenter studies.
As of 2026, more than 142 patients have received Ziplyft lid lifts in clinical trials and practice settings, with patient numbers growing rapidly as adoption increases.
Ziplyft’s safety profile is excellent. Across 130+ cases, surgeons report very low rates of wound healing issues, no significant bleeding, and no suture-related problems.
All practitioners are trained using Osheru’s standardized protocol, including video instruction, hands-on practice, and ongoing support. Certification is required, and patient outcomes are tracked for quality assurance.
Patients receive local numbing, the device is placed and compression applied, excess skin is removed with a protected blade, and the site is closed instantly with adhesive. The whole process takes minutes and does not require stitches or bandages.
Typically, 10–15 minutes from preparation to completion per eye, far less than conventional eyelid procedures.
Most patients experience little to no pain due to local anesthesia and the gentle, controlled nature of the compression.
No general anesthesia or IV sedation is needed. Only local anesthesia is used, minimizing system risk and allowing for fast recovery.
Patients will leave without visible stitches or bandages. Mild swelling or pinkness is normal, but most return to daily activities within a few days.
Most patients are “event-ready” with minimal swelling or bruising within 5-7 days, compared to 2–3 weeks for classic eyelid surgery.
Many patients return to work or social activities within a week, some in as little as 3 days.
Ziplyft’s CoCo technique significantly minimizes both; clinical experience shows less than half the usual bruising or swelling seen with older methods.
Natural-looking outcomes are typically visible as soon as mild swelling subsides—often 7–10 days. Scarring is minimal and hidden in the crease.
The incision is carefully placed in the natural eyelid crease. Because closure is by adhesive, not stitches, long-term scarring is barely perceptible for most patients.
Ziplyft is minimally invasive, bloodless, and sutureless, usually performed in-office in 10 minutes with fast, adhesive-based closure and recovery. Traditional blepharoplasty is more invasive, involves significant bruising/swelling, and requires OR time, stitches, and follow-up for suture removal.
No. The closure is performed with a medical adhesive, eliminating all stitches and associated discomfort.
No. The device’s compression action prevents bleeding so cautery is never required.
Ziplyft is about three times faster—10 minutes per case compared to up to an hour for classic approaches.
Because Ziplyft is less traumatic, avoids sutures, and assures precise compression, results are often more natural and symmetric, with less scarring.
Ziplyft’s design supports symmetric placement and tension-free healing, reducing asymmetry and wound issues commonly seen with stitches.
Yes, clinical results show strong wound sealing and rapid healing, with low rates of dehiscence and no stitch-related complications.
Patients needing ptosis repair, complex revision, or certain anatomic variants may still require traditional methods.
Yes, Ziplyft is not for “skin-only” cases; However, for significant fat or ptosis, a supplemental minimal incision or alternative may be needed.
Ziplyft is generally similar to classic procedures, but recovery is faster, and fewer follow-ups are required—for a better experience.
Ziplyft is an FDA Class I device, supported by over 130 successful cases, peer-reviewed data, patents, and real-world testimonials. It is performed by certified doctors—not a spa or “DIY” solution.
Yes, for “skin-only” eyelid aging, the results are as permanent as traditional eyelid lifts. Aging continues, but outcomes are comparable by all current clinical measures.
Yes; if further adjustment is ever needed, future enhancements can be performed, either with Ziplyft again or, if appropriate, standard techniques.
Most patients report that friends notice their refreshed appearance, but cannot tell a procedure was performed—there are no obvious scars or “hollowed out-operated” look.
Often yes. Because compression prevents bleeding, many patients on blood thinners are eligible, but you must consult the provider for specific risks.
Future procedures or enhancements remain possible; Ziplyft does not burn bridges for classic surgery or revision, should additional aging occur.
Every patient is different but most patients are typically socially presentable in 5-7days, with far less bruising compared to traditional approaches.
A medical adhesive is applied to seal the skin edges securely, supporting strong, safe, tension-free healing.
Satisfaction scores are very high; as with any cosmetic procedure, outcomes vary, but no serious adverse events have been reported to date.
Pricing is comparable to traditional surgery. Practices report high patient willingness to pay for reduced bruising and downtime and symmetric results.
Most clinicians achieve comfort within 3 procedures using Osheru’s onboarding kit, videos, and training modules.
Yes, only standard in-office procedural setup and local anesthetic are required—no OR, no IV sedation, no cautery.
Providers receive device kits, step-by-step materials, in-person or virtual training, and ongoing support. Customer and outcomes tracking is standard.
Procedures average 10 minutes; centers report higher throughput and margins per hour compared to classic blepharoplasty, with strong patient-driven demand.
Minimal retraining is needed—most staff find adhesive closure and workflow easier than standard postoperative suture management.
Clinical outcomes to date show adhesive is as safe and often leads to smoother, finer scars with fewer postoperative visits.
Yes, “skin-only,” upper eyelid redundancy are optimal patients. Patients needing extensive fat or muscle repair may require additional incisions.
Yes. Should a challenge arise, conversion to an open or suture-based technique is possible.
Osheru provides published studies, rigorous clinical data (>130 cases), and ongoing peer-reviewed outcomes to address any skepticism.
The platform roadmap includes expansion but lower lids and some ethnic variations remain future indications if needed.
